Supplemental material
Modern Rheumatology
Volume 25, 2015 - Issue 2
Open access
2,566
Views
15
CrossRef citations to date
0
Altmetric
Review Article
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, JapanCorrespondence[email protected] [email protected]
, Nobuyuki MiyasakaEmeritus Professor, Tokyo Medical and Dental University, Tokyo, Japan
, Shinichi KawaiDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan
, Naonobu SugiyamaPfizer Japan, Tokyo, JapanCorrespondence[email protected] [email protected]
, Hirotoshi YuasaPfizer Japan, Tokyo, Japan
, Noriaki YamashitaPfizer Japan, Tokyo, Japan
, Noriko SugiyamaPfizer Japan, Tokyo, Japan
, Lorin Craig WagerlePfizer Inc, Collegeville, PA, USA
, Bonnie VlahosPfizer Inc, Collegeville, PA, USA
& Joseph WajdulaPfizer Inc, Collegeville, PA, USA
show all
Pages 173-186
|
Received 09 Jan 2014, Accepted 05 Apr 2014, Published online: 20 May 2014
Related Research Data
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.
Source:
Springer Science and Business Media LLC
Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.